MondayJan 11, 2021 12:29 pm

Mobius Interactive Ltd. Meeting Need for Growing eSports Betting Market

Average income of a pro-esports player is $400,000 Audience for esports is expected to reach 495 million by the end of 2020 eSports betting market forecasted at $17.2 billion globally by the end of 2020 Mobius Interactive, an online gaming operator, is capitalizing on the quickly growing eSports segment. Through its brand, MobiusBet, the company attracts a network of high-net-worth gamers worldwide with loyalty programs, targeted gamification and product merchandising. The world of gaming has changed significantly in the last four decades, and so have the rewards. The earliest known video game competition took place at Stanford University on Oct.…

Continue Reading

MondayJan 11, 2021 12:20 pm

New Optimism for EVs in 2021 Drives Growth Opportunities for ev Transportation Services Inc.

The new year, with a pro-EV president and recent inclusion into a regional municipal group purchasing program, creates exciting potential for evTS evTS’s vehicles and fleet-management solutions designed to provide environmentally friendly platform New 2021 FireFly ESV model offers attractive updated features, upgrade options The election of a new pro-EV president, and an agreement to sell its all-electric utility vehicles through a group purchasing program, represents significant potential for ev Transportation Services. Founded in 2015, the company’s focus on its electric vehicle (“EV”) manufacturing mission could be seeing an impressive payoff in the coming months. President-elect Joe Biden, who will…

Continue Reading

MondayJan 11, 2021 12:10 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will present at the Biotech Showcase(TM) Digital 2021 Conference. According to the update, the conference is taking place online between January 11-15 and will feature prerecorded sessions of company presentations. Dr. James Woody, Chief Executive Officer, will provide an overview of 180 Life Sciences and the company’s progress in key programs. In addition, 180 Life Sciences will host one-on-one meetings with investors and…

Continue Reading

MondayJan 11, 2021 11:57 am

CannAssist International Corp.’s (CNSC) Proprietary Technology Offers Superior Absorption, Efficacy

Imperial College of London review suggests that cannabis-based medicinal products offer significant relief from intractable epilepsy CNSC produces proprietary CBD products under the Xceptol brand that are created with branded Technology CiBiDinol that increases absorbability, bioavailability, shelf life Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Researchers from the Imperial College of London recently conducted a review that examined the impact of cannabis-based medicinal products containing cannabidiol (“CBD”) on the frequency of epileptic seizures and determined that they offer patients significant relief from intractable epilepsy (https://ibn.fm/TDwpd). As scientific evidence…

Continue Reading

MondayJan 11, 2021 11:47 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces New CFO, General Counsel

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) chairman and CEO Roger McIntyre today announced the company's appointment of Stephen R. Brooks as its new chief financial officer and Peter Rizakos as the firm's new general counsel. According to the update, these appointments complete the company's new top management team put into place by Dr. McIntyre and the Champignon Board of Directors.  "These new management additions ready us for the future where the Company's clinical products and services will help meet the enormous public need that is creating significant public demand for improved, ketamine-based treatments that are capable of rapid response…

Continue Reading

MondayJan 11, 2021 11:35 am

EV Battery Costs Down Nearly 90%, Net Element Inc. (NASDAQ: NETE) Upshifting into EV Industry via Mullen Technologies Merger

Recent industry report suggests that EV battery costs are down nearly 90% Analysts predicting that falling EV battery prices will make EVs cost-competitive in several years NETE planning to divest its current business model in order to enter EV industry through reverse merger with privately-held Mullen Technologies Inc. Mullen currently taking pre-orders for five-passenger MX-05 SUV, Dragonfly K50 sports car Rapidly falling electric vehicle (“EV”) battery prices are fueling predictions that it will be easier and cheaper to build and market EVs within a few years (https://ibn.fm/MYD7s). In a bold move aiming to leverage these changing market conditions, Net Element (NASDAQ:…

Continue Reading

MondayJan 11, 2021 11:19 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) Announces Strategic Partnership with Kernel

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, is excited to announce that it has entered into an agreement with neurotech pioneer HI, LLC dba Kernel (“Kernel”) to leverage its innovative technology, Kernel Flow (“Flow”), for its upcoming sponsored clinical work. “Access to Kernel’s innovative Flow technology adds another exciting dimension to the investigative work that Cybin is doing to develop breakthrough treatments for mental health disorders such as depression and addiction. Currently, clinical investigators rely on limited subjective information from patients. The ability to collect quantitative data from our sponsored drug development programs is potentially…

Continue Reading

FridayJan 08, 2021 12:36 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE) Shifts to Drive Opportunity in the EV Fast Lane

Net Element (NASDAQ: NETE) is a financial technology company in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately-held Mullen Technologies Inc. On the heels of success in the global financial technology sector, providing next-generation electronic payments solutions spanning across point-of-sale, e-commerce and mobile devices, Net Element is preparing for life in the fast lane as it shifts into the EV space. Under the leadership of CEO Oleg Firer, a veteran entrepreneur and corporate turn-around specialist, Net Element realized exponential revenue growth from $0 in 2013 to $65…

Continue Reading

FridayJan 08, 2021 12:21 pm

QualityStocksNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) COO Shines the Spotlight on Proprietary Tech, Unique Value Proposition

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an innovative agriculture biotech company focused on providing natural biological protection for high value crops, was featured in a recent SmallCap-Investor interview. The company’s COO Colin Bletsky joined the interview to discuss MustGrow and its unique value proposition and ambitious plans for the future. Bletsky explained that a rigorous scientific process stands behind MustGrow’s proprietary technology, in which the company has invested more than $10 million. MustGrow has also conducted an estimated 110 studies in the field and worked with third-party companies, leading to the ownership of approximately 100 patents The company is…

Continue Reading

FridayJan 08, 2021 12:19 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces $3M Registered Direct Offering

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 3,650,840 shares of its common stock at a purchase price of $0.842 per share. The company expects to secure gross proceeds of approximately $3.0 million in the registered direct offering priced at-the-market under Nasdaq rules. Predictive Oncology has also agreed to issue to the investors unregistered warrants to purchase an aggregate of up to 1,825,420 shares of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered